Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_assertion type Assertion NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_head.
- NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_provenance.
- NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_assertion evidence source_evidence_literature NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_provenance.
- NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_assertion SIO_000772 17606310 NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_provenance.
- NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_assertion wasDerivedFrom befree-20150227 NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_provenance.
- NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_assertion wasGeneratedBy ECO_0000203 NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_provenance.